Compare BRKR & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRKR | G |
|---|---|---|
| Founded | 1960 | 1997 |
| Country | United States | Bermuda |
| Employees | N/A | 140000 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Professional Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.4B |
| IPO Year | 2000 | 2007 |
| Metric | BRKR | G |
|---|---|---|
| Price | $58.65 | $33.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $48.54 | ★ $49.50 |
| AVG Volume (30 Days) | 2.1M | ★ 3.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 0.58% | ★ 2.21% |
| EPS Growth | N/A | ★ 9.82 |
| EPS | 0.02 | ★ 0.86 |
| Revenue | $1,895,600,000.00 | ★ $2,279,438,000.00 |
| Revenue This Year | $6.30 | $9.20 |
| Revenue Next Year | $3.81 | $7.27 |
| P/E Ratio | $2,706.00 | ★ $37.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.53 | $28.78 |
| 52 Week High | $56.22 | $48.64 |
| Indicator | BRKR | G |
|---|---|---|
| Relative Strength Index (RSI) | 85.11 | 52.27 |
| Support Level | $46.84 | $28.78 |
| Resistance Level | N/A | $35.54 |
| Average True Range (ATR) | 2.19 | 1.41 |
| MACD | 1.32 | 0.37 |
| Stochastic Oscillator | 99.18 | 93.25 |
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.